Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
SLU-PP-332 Is A Small-Molecule Pan-ERR Agonist That Targets ERRα, ERRβ, And ERRγ, With The Highest Potency At ERRα. It Is Widely Used In Preclinical Research To Study Mitochondrial Biogenesis, Oxidative Metabolism, And Exercise-Mimetic Cellular Programs. For Research Use Only—Not For Human Or Veterinary Application.
Description
SLU-PP-332 Is A Potent Agonist Of The Estrogen-Related Receptors ERRα, ERRβ, And ERRγ, Designed To Activate Energy-Regulating Pathways Within Cells. It Is Most Frequently Used In Laboratory Studies To Model Endurance-Like Metabolic Responses And To Explore Mitochondrial Biogenesis And Oxidative Metabolism.
Through Activation Of Nuclear Receptors And Co-Activators Such As PGC-1α, SLU-PP-332 May Upregulate Genes Associated With Mitochondrial Function, Oxidative Phosphorylation, And Lipid Oxidation. This Pathway Is Believed To Mimic The Physiological Effects Of Endurance Exercise, Potentially Improving Energy Efficiency And Cellular Metabolism In Research Models.
In Studies Involving Metabolic Dysfunction, SLU-PP-332 Has Been Observed To Reduce Adiposity And Improve Glucose Tolerance. These Outcomes Are Often Accompanied By Apparent Enhancements In Insulin Sensitivity And Lipid Handling, Positioning ERR Activation As A Relevant Research Target In Obesity And Metabolic Disease.
Additional Research Suggests That SLU-PP-332 May Reverse Mitochondrial Impairment And Modulate Inflammatory Signaling. Findings From Aging Models Indicate Its Potential To Restore Cellular Respiration And Reduce Oxidative Stress Within Muscle, Adipose, And Organ Tissue.
SLU-PP-332 Is Provided As A Research Compound For The Controlled Study Of ERR Activation And Mitochondrial Signaling Pathways. For Research Use Only, Not For Human Or Veterinary Use.
SLU-PP-332 Is A Small-Molecule Pan-ERR Agonist That Targets ERRα, ERRβ, And ERRγ, With The Highest Potency At ERRα. It Is Widely Used In Preclinical Research To Study Mitochondrial Biogenesis, Oxidative Metabolism, And Exercise-Mimetic Cellular Programs. For Research Use Only—Not For Human Or Veterinary Application.
Description
SLU-PP-332 Is A Potent Agonist Of The Estrogen-Related Receptors ERRα, ERRβ, And ERRγ, Designed To Activate Energy-Regulating Pathways Within Cells. It Is Most Frequently Used In Laboratory Studies To Model Endurance-Like Metabolic Responses And To Explore Mitochondrial Biogenesis And Oxidative Metabolism.
Through Activation Of Nuclear Receptors And Co-Activators Such As PGC-1α, SLU-PP-332 May Upregulate Genes Associated With Mitochondrial Function, Oxidative Phosphorylation, And Lipid Oxidation. This Pathway Is Believed To Mimic The Physiological Effects Of Endurance Exercise, Potentially Improving Energy Efficiency And Cellular Metabolism In Research Models.
In Studies Involving Metabolic Dysfunction, SLU-PP-332 Has Been Observed To Reduce Adiposity And Improve Glucose Tolerance. These Outcomes Are Often Accompanied By Apparent Enhancements In Insulin Sensitivity And Lipid Handling, Positioning ERR Activation As A Relevant Research Target In Obesity And Metabolic Disease.
Additional Research Suggests That SLU-PP-332 May Reverse Mitochondrial Impairment And Modulate Inflammatory Signaling. Findings From Aging Models Indicate Its Potential To Restore Cellular Respiration And Reduce Oxidative Stress Within Muscle, Adipose, And Organ Tissue.
SLU-PP-332 Is Provided As A Research Compound For The Controlled Study Of ERR Activation And Mitochondrial Signaling Pathways. For Research Use Only, Not For Human Or Veterinary Use.